Learning Objectives:

1. Understand evolving experimental applications of gene therapy for neurodegenerative disease.

2. Understand the role of focused ultrasound lesioning for treatment of movement disorders.

3. Understand the mechanism and role of focused ultrasound blood brain barrier disruption for treatment of neurodegenerative disorders.

Session date: 
08/14/2019 - 8:30am to 9:30am CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael G. Kaplitt, MD, PhD